Search details
1.
The role of [18 F]FDOPA PET as an adjunct to conventional MRI in the diagnosis of aggressive glial lesions.
Eur J Nucl Med Mol Imaging
; 2024 Apr 19.
Article
in English
| MEDLINE | ID: mdl-38637354
2.
CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.
Am J Hematol
; 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38586986
3.
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study.
Eur J Nucl Med Mol Imaging
; 50(9): 2727-2735, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37086272
4.
Differentiating high-grade glioma progression from treatment-related changes with dynamic [18F]FDOPA PET: a multicentric study.
Eur Radiol
; 33(4): 2548-2560, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36367578
5.
Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Eur Radiol
; 33(10): 7089-7098, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37148355
6.
Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
Am J Hematol
; 96(7): 823-833, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-33864703
7.
Integration of dynamic parameters in the analysis of 18F-FDopa PET imaging improves the prediction of molecular features of gliomas.
Eur J Nucl Med Mol Imaging
; 47(6): 1381-1390, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31529264
8.
CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network.
Blood
; 139(5): 792-796, 2022 02 03.
Article
in English
| MEDLINE | ID: mdl-34871363
9.
Epileptic seizures in diffuse low-grade gliomas in adults.
Brain
; 137(Pt 2): 449-62, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24374407
10.
Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France.
J Neurooncol
; 120(3): 547-55, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25151505
11.
Neoadjuvant chemotherapy may optimize the extent of resection of World Health Organization grade II gliomas: a case series of 17 patients.
J Neurooncol
; 113(2): 267-75, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-23479036
12.
Radiological evolution of progestogen-induced meningioma: A monocentric retrospective study.
Fundam Clin Pharmacol
; 37(4): 868-878, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36692232
13.
Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life.
J Neurooncol
; 106(2): 353-66, 2012 Jan.
Article
in English
| MEDLINE | ID: mdl-21785913
14.
18F-FDOPA PET for the Noninvasive Prediction of Glioma Molecular Parameters: A Radiomics Study.
J Nucl Med
; 63(1): 147-157, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34016731
15.
Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients.
Front Oncol
; 12: 827897, 2022.
Article
in English
| MEDLINE | ID: mdl-35311144
16.
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study.
Cancers (Basel)
; 14(22)2022 Nov 09.
Article
in English
| MEDLINE | ID: mdl-36428602
17.
Dynamic 18F-FDopa PET Imaging for Newly Diagnosed Gliomas: Is a Semiquantitative Model Sufficient?
Front Oncol
; 11: 735257, 2021.
Article
in English
| MEDLINE | ID: mdl-34676168
18.
High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors.
Chin Clin Oncol
; 10(3): 26, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33752411
19.
Effects of Carbidopa Premedication on 18F-FDOPA PET Imaging of Glioma: A Multiparametric Analysis.
Cancers (Basel)
; 13(21)2021 Oct 24.
Article
in English
| MEDLINE | ID: mdl-34771504
20.
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial.
Med Oncol
; 39(1): 4, 2021 Nov 05.
Article
in English
| MEDLINE | ID: mdl-34739635